Home

According to a press release, the new balloons broaden physicians’ treatment options for peripheral artery disease (PAD) patients with a high risk of restenosis and expand the Stellarex portfolio, which has a proven significant treatment effect and high safety profile. The 200mm and 150mm Stellarex 0.035” low-dose DCBs are now available in the USA and will be rolled out to other markets in due course.

“With its unique coating, Stellarex is unlike any other DCB in the industry for the treatment of PAD,” said Chris Landon, general manager, Image Guided Therapy Devices at Philips. “Stellarex is the only low-dose drug-coated balloon with a proven treatment effect at three years compared to the existing standard of care in the USA and Europe. By expanding our range of Stellarex balloons, we are adding to the treatment options that physicians can use to provide optimal care for each patient with peripheral arterial disease.”

All Philips’ Stellarex DCBs feature EnduraCoat technology, a coating consisting of a polyethylene glycol excipient with amorphous and crystalline paclitaxel particles dispersed in it. The coating provides drug transfer and effective drug residency coupled with high coating durability and minimal particulate loss, thereby enabling a low therapeutic drug dose. The Stellarex balloon is now available in 40, 60, 80, 100, 120, 150, and 200mm lengths for the treatment of lesions in the superficial femoral and popliteal arteries with vessel diameters of 4–6mm.

The results of third-party analyses of patient-level data from worldwide clinical trials of the Philips Stellarex 0.035″ low-dose DCB in lengths under 150mm were recently published in Circulation. Primary safety analysis of Philips Stellarex DCB three-year data, comprising a large published, pooled set of randomised controlled trial (RCT) data for a single paclitaxel-based device, showed no difference in mortality between patients treated with the Philips Stellarex DCB and those treated with percutaneous angioplasty, the current standard of care. The analyses represent one of industry’s most extensive and rigorous safety assessments of a paclitaxel-based device.

Source VascularNews

Duc Tin Clinic

Chia sẽ qua facebook bài: Philips receives FDA approval for low-dose drug-coated balloons 16th October 2019

Chia sẽ qua google bài: Philips receives FDA approval for low-dose drug-coated balloons 16th October 2019

Chia sẽ qua twitter bài: Philips receives FDA approval for low-dose drug-coated balloons 16th October 2019

Chia sẽ qua MySpace bài: Philips receives FDA approval for low-dose drug-coated balloons 16th October 2019

Chia sẽ qua LinkedIn bài: Philips receives FDA approval for low-dose drug-coated balloons 16th October 2019

Chia sẽ qua stumbleupon bài: Philips receives FDA approval for low-dose drug-coated balloons 16th October 2019

Chia sẽ qua icio bài: Philips receives FDA approval for low-dose drug-coated balloons 16th October 2019

Chia sẽ qua digg bài: Philips receives FDA approval for low-dose drug-coated balloons 16th October 2019

Chia sẽ qua yahoo bài: Philips receives FDA approval for low-dose drug-coated balloons 16th October 2019

Tin tức liên quan

Vesteck completes first-in-human use of several Suture-Tight devices

Age is just a number: Individual patient data meta-analysis probes safety of CEA in the elderly

Artificial intelligence can predict risk of complications after endovascular aneurysm repair

Bluegrass Vascular announces Journal of Vascular Surgery paper reporting use of Surfacer system

Vascular access creation: EndoAVF keeps future options open, but is not a replacement for surgical fistulas

SUPPORT CONSULTANT

Make an Appointment

I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

I sincerely thank you !. Tel: 0938303275

Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.